Envigo appoints Chief Commercial Officer and President of EMEA Operations

Oct 9, 2017

The two new appointments of a Chief Commercial Officer and President of EMEA Operations have been made at a time of growth for Envigo during which the organization has been focused on improving the quality of the customer experience for its global customer base across the pharmaceutical, chemicals, and crop protection industries. Both of the positions report directly into Dr. Adrian Hardy, Chief Executive Officer of Envigo. Craig Boyd has joined Envigo in the position of Chief Commercial Officer. Craig has more than 20 years’ experience in various global pharmaceutical markets and has worked extensively in the US, Asia, Europe ...

Read More

H&T Presspart granted European Patent for the eMDITM Connected Inhaler

Oct 9, 2017

H&T Presspart, the market leader in respiratory drug delivery components and devices, has been granted a European patent for its latest product, the eMDI connected metered-dose inhaler.   The patent granted focuses on an innovative design to allow the eMDI to validate if a patient has completed a successful actuation of the eMDI inhaler. This is the first granted patent out of a number of running patent applications for H&T Presspart’s eMDI, which further strengthens H&T Presspart’s IP position and demonstrates the strong commitment to the connected medical device market. H&T Presspart’s eMDI is the first market-ready, fully embedded, connected metered-dose ...

Read More

Harmony Biosciences Acquires US Rights to Pitolisant from Bioproject and Raises $270 Million in Equity Financing

Oct 6, 2017

Funding will accelerate development and registration of a novel drug for adults suffering from narcolepsy Plymouth Meeting, PA — Biopharmaceutical company Harmony Biosciences, LLC (Harmony), a member of the Paragon Biosciences (Paragon) corporate family, today announced it has acquired the exclusive US right to develop, register and market the drug pitolisant from French company Bioprojet SCR (Bioprojet).  Harmony, established and guided by Paragon and its experienced team, also announced that it completed a $270 million equity financing to facilitate this acquisition and accelerate its ability to address unmet needs for patients with sleep and other central nervous system disorders. Pitolisant ...

Read More

Record year sees pharma marketing specialist attract investment

Oct 5, 2017

PHARMACEUTICAL and biotech outsourcing expert ramarketing is eyeing up a US base after attracting backing from a high profile pharmaceutical business figure. The six-figure investment from industry expert Fiona Cruickshank OBE, who founded The Specials Laboratory, follows a record year for the digital, marketing and PR business that has seen it grow by 70% and double staff numbers to over 20. Having operated in the contract services sector for many years, ramarketing works with some of the most high-profile names in the sector including Recipharm, Eurofins and TraceLink to help raise their profile, generate leads and ultimately grow their business. ...

Read More

groninger and Martin Christ Show Flexibility in Fill / Finish & Freeze Drying

Oct 5, 2017

Ready for your Visions @ CPhI worldwide As time-to-market cycles in the pharmaceutical industry grow shorter and shorter, the machine concepts need to offer more flexibility. As an expert for aseptic filling and closing systems, groninger shows its machine solution FlexPro 50 for small batch production from October 24 to 26 at the CPhI worldwide show in Frankfurt. In Turn-Key partnership with Martin Christ Freeze Drying Systems, there will be expertise from fill/finish to freeze drying on one booth.  Like many other sectors, the pharmaceutical industry also experiences a trend towards greater specialization in medicines, which results in smaller batch ...

Read More